Bone Biologics BBLGW
NASDAQ BBLGW
$8.24 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Bone Biologics Corp (BBLGW) EBT (2010 - 2025)

Bone Biologics (BBLGW) posted quarterly EBT of -$773475.0 for Q4 2025, up 52.3% year-over-year from -$507856.5 in Q4 2024, and up 15.03% quarter-over-quarter from -$910246.0 in Q3 2025.

Bone Biologics Corp (BBLGW) EBT (2010 - 2025) Analysis & Trends

Bone Biologics (BBLGW) has reported EBT for 16 consecutive years, with -$773475.0 the latest figure, recorded in Q4 2025.

  • In Q4 2025, EBT rose 52.3% year-over-year to -$773475.0; the TTM figure through Dec 2025 stood at -$3.4 million (up 19.68% YoY), while the FY2025 annual figure was -$27.9 million, down 8.04% from the prior year.
  • EBT rose to -$773475.0 in Q4 2025 per BBLGW's latest filing, from -$910246.0 in the prior quarter.
  • Across five years, EBT topped out at -$176137.0 in Q4 2021 and bottomed at -$21.6 million in Q4 2022.
  • Historically, EBT has averaged -$3.2 million across 5 years, with a median of -$906763.5 in 2024.
  • Annual changes were most pronounced in 2022 — EBT tumbled 12185.38% — and 2024, when it surged 92.48%.
  • Bone Biologics' EBT stood at -$176137.0 in 2021, then sank by 12185.38% to -$21.6 million in 2022, then gained by 0.32% to -$21.6 million in 2023, then soared by 92.48% to -$1.6 million in 2024, then soared by 52.3% to -$773475.0 in 2025.
  • Business Quant data shows BBLGW's EBT at -$773475.0 in Q4 2025, -$910246.0 in Q3 2025, and -$741421.0 in Q2 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2025 -773,475.00
Sep 30, 2025 -910,246.00
Jun 30, 2025 -741,421.00
Mar 31, 2025 -1.02 Mn
Dec 31, 2024 -1.62 Mn
Sep 30, 2024 -967,884.00
Jun 30, 2024 -794,518.00
Mar 31, 2024 -903,281.00
Dec 31, 2023 -21.57 Mn
Sep 30, 2023 -2.10 Mn
Jun 30, 2023 -3.04 Mn
Mar 31, 2023 -3.15 Mn
Dec 31, 2022 -21.64 Mn
Sep 30, 2022 -1.22 Mn
Jun 30, 2022 -469,304.00
Mar 31, 2022 -656,422.00
Dec 31, 2021 -176,137.00
Sep 30, 2021 -509,303.00
Jun 30, 2021 -491,898.00
Mar 31, 2021 -431,747.00